K.N. Chi

Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide

Krista Noonan, Scott North, Rhonda L. Bitting et al. · Annals of Oncology · 2013 · 339 citations · Full text

Urology, Oncology, Abiraterone Acetate +7

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

D. Scott Ernst, I. F. Tannock, Eric Winquist et al. · Journal of Clinical Oncology · 2003 · 248 citations

Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group

Christina M. Canil, Malcolm J. Moore, Eric Winquist et al. · Journal of Clinical Oncology · 2005 · 207 citations

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial

K.N. Chi, Shahneen Sandhu, Matthew R. Smith et al. · Annals of Oncology · 2023 · 178 citations · Full text

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial

Cora N. Sternberg, Johann S. de Bono, K.N. Chi et al. · Annals of Oncology · 2014 · 127 citations · Full text

Urology, Oncology, Elderly Patients +6